A geldanamycin derivative exhibiting significant preliminary in vivo activity,
particularly significant oral in vivo activity, and a method of treating or preventing
cancer in a host comprising administering a geldanamycin derivative to a host in
an amount sufficient to treat or prevent cancer.
